ArticleOncotarget2016

Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area.

Mu-Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.